The seventh annual Social Media Campaign #MedSafetyWeek was launched on the 7th of November, 2022 by the National Pharmacovigilance Centre, DRAP, which was observed until 13th November 2022, to encourage everyone to report suspected side effects of medicines. The International campaign was led by the Uppsala Monitoring Centre (UMC), the World Health Organisation (WHO) Collaborating Centre for International Drug Monitoring.
This year’s global campaign involved medicines regulators from 81 countries and focused on the key role of every healthcare professional, patient, and caregivers who reports a suspected side effect and contributes to using medicines safely. This campaign was supported by the members of the International Coalition of Medicines Regulatory Authorities (ICMRA)
Every report to the National Pharmacovigilance Centre, DRAP helps to improve the safety of medicines for all patients.
People are encouraged to report suspected side effects of medicines as part of the global #MedSafetyWeek social media campaign
Why Reporting is required?
All medicines may cause side effects in some patients, so there are steps in place to continuously monitor their safety after they are placed on the market. The purpose of safety monitoring is to gain more information about known side effects and find out about new ones. Regulatory bodies operate systems to detect and analyse those side effects and prevent harm to future patients.
The National Pharmacovigilance Centre, DRAP, collects, organises, and investigates reports of suspected side effects / Adverse effects.
By reporting suspected side effects, you are actively participating in identifying emerging safety issues, so that DRAP can take action when necessary and protect you and others from harm.
Every Report is important for us
Every report made by a patient, a healthcare professional, or a caregiver plays a key role in gaining more knowledge about the benefits and risks of medicines in clinical use and allows action to be taken to minimize risks and can result in better tailored prescribing advice, which can improve patient outcomes.
- Med Safety Mobile App (Android/iOS)
- Med Vigilance E-Reporting System
- Yellow reporting form
- Email: npc∂dra.gov.pk
- Landline: 051-9107-413 / 299
Are you a Pharmacist?
You are the first person patients go to when they have questions about their medicines. Please report any new side effects of a medicine via the [Med Safety App & E reporting https://primaryreporting.who-umc.org/PK
When you report a suspected side effect from a medicine, we learn more about it. This way healthcare providers can pick the best medicine for each patient. Thank you for reporting 👉 Download the Med Safety App or report online #MedSafetyWeek #ReportSideEffects #PatientSafety pic.twitter.com/aSVoSWijhd— Drug Regulatory Authority of Pakistan (@DRA_Pakistan) November 12, 2022